Table 2.
Immunostaining | Normal (%) | Precursor lesions (%) | ESCC (%) | P-value | ||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||
LGIN | HGIN | P 1 | P 2 | P 3 | P 4 | P 5 | P 6 | |||
Low | 59 (60.2) | 12 (19.0) | 6 (16.7) | 34 (30.2) | 0.110 | 0.114 | 1.11×10-5 | 2.84×10-7 | 7.83×10-6 | 0.768 |
High | 39 (39.8) | 51 (81.0) | 30 (83.3) | 79 (69.8) |
P 1: ESCC vs. LGIN; P 2: ESCC vs. HGIN; P 3: ESCC vs. Normal; P 4: LGIN vs. Normal; P 5: HGIN vs. Normal; P 6: LGIN vs. HGIN. P < 0.05 was considered statistically significant.